HEPATOCYTES--TRANSPLANTATION AND EXTRACORPOREAL LIVER SUPPORT

许多肝功能衰竭的患者会在等待期间死亡 移植。生物人工肝辅助系统(BAL)，一个装置 利用猪肝细胞，已经被开发出来。在上一年中 BAL的安全性已经确定，导致了FDA的设计 获得批准、行业支持的多中心临床试验始于 1996年初确定BAL在等待肝脏患者中的疗效 移植。

Many patients with liver failure will die while awaiting transplantation. A Bioartificial Liver Assist System (BAL), a device using porcine hepatocytes, has been developed. During the previous year the safety of BAL had been established, leading to the design of an FDA approved, industry supported multicenter clinical trial which began in early 1996 to determine the efficacy of BAL in patients awaiting liver transplantation.